69121-56-8

Basic information

• Product Name: 3H-Pyrazol-3-one, 2-cyclohexyl-1,2-dihydro-1,5-dimethyl-
• Synonyms: 2-cyclohexyl-1,5-dimethyl-1,2-dihydro-pyrazol-3-one;2-cyclohexyl-1,5-dimethyl-1,2dihydro-3H-pyrazole-3-one;2-Cyclohexyl-1,5-dimethyl-1,2-dihydro-pyrazol-3-on;3H-?Pyrazol-?3-?one, 2-?cyclohexyl-?1,?2-?dihydro-?1,?5-?dimethyl-
• CAS NO: 69121-56-8
• Molecular Formula: C11H18N2O
• Molecular Weight: 194.277
• Mol File: 69121-56-8.mol

Chemical Properties

• CAS DataBase Reference: 3H-Pyrazol-3-one, 2-cyclohexyl-1,2-dihydro-1,5-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Pyrazol-3-one, 2-cyclohexyl-1,2-dihydro-1,5-dimethyl-(69121-56-8)
• EPA Substance Registry System: 3H-Pyrazol-3-one, 2-cyclohexyl-1,2-dihydro-1,5-dimethyl-(69121-56-8)

Safety Data

• Hazardous Substances Data: 69121-56-8(Hazardous Substances Data)

Upstream product

• 6498-34-6 cyclohexylhydrazine 
• 24214-73-1 cyclohexylhydrazine hydrochloride 
• 7440-44-0 pyrographite 
• 858838-09-2 2-cyclohexyl-5-methyl-1H-pyrazol-3(2H)-one 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 

Relevant articles and documents

CARBOXAMIDE DERIVATIVES

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

CARBOXAMIDE DERIVATIVES

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists

The discovery and optimization of a novel class of potent CCR3 antagonists is described. Details of synthesis and SAR are given together with some ADME properties of selected compounds. An optimal balance between activities, physicochemical properties, and in vitro metabolic stability was reached by the proper choice of substituents.

PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, X, and n are as defined for Formula (I) in the description, processes for the preparation of the compounds and new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and the use of the compounds in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction.

Dihydropyrazolone herbicide

The new herbicide, 2-cyclohexyl-4-iodo-1,5-dimethyl-1,2-dihydro-3H-pyrazol-3-one, is described and its preparation and use to control undesired plant growth are exemplified.